Clinical Trials Directory

Trials / Completed

CompletedNCT02242565

Safety and Effectiveness of Different ShangRing Device Sizes for Adult Male Circumcision in Lusaka, Zambia

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
500 (actual)
Sponsor
FHI 360 · Academic / Other
Sex
Male
Age
18 Years – 49 Years
Healthy volunteers
Accepted

Summary

The purpose of this study was to assess the safety, effectiveness and acceptability of providing a reduced number of ShangRing sizes for adult voluntary medical male circumcision (VMMC) within routine service delivery in Lusaka, Zambia.

Detailed description

We conducted a randomized controlled trial and enrolled 500 HIV-negative men aged 18-49 years at 3 clinics. Participants were randomized to 1 of 2 study arms (Standard Sizing arm vs Modified Sizing arm) in a 1:1 ratio. All 14 adult ShangRing sizes (40-26 mm inner diameter, each varying by 1 mm) were available in the Standard Sizing arm; the Modified Sizing arm used every other size (40, 38, 36, 34, 32, 30, 28 mm inner diameter). Each participant was scheduled for 2 follow-up visits: the removal visit (day 7 after placement) and the healing check visit (day 42 after placement), when they were evaluated for adverse events (AEs), pain, and healing.

Conditions

Interventions

TypeNameDescription
DEVICEShangRingShangRing device for male circumcision

Timeline

Start date
2014-10-01
Primary completion
2015-09-01
Completion
2015-12-01
First posted
2014-09-17
Last updated
2017-10-02

Locations

2 sites across 1 country: Zambia

Source: ClinicalTrials.gov record NCT02242565. Inclusion in this directory is not an endorsement.